BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1264 related articles for article (PubMed ID: 16403636)

  • 1. Genomic DNA methylation: the mark and its mediators.
    Klose RJ; Bird AP
    Trends Biochem Sci; 2006 Feb; 31(2):89-97. PubMed ID: 16403636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation and methyl-CpG binding proteins: developmental requirements and function.
    Bogdanović O; Veenstra GJ
    Chromosoma; 2009 Oct; 118(5):549-65. PubMed ID: 19506892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian methyl-binding proteins: what might they do?
    Joulie M; Miotto B; Defossez PA
    Bioessays; 2010 Dec; 32(12):1025-32. PubMed ID: 20886526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced genomic cytosine methylation and defective cellular differentiation in embryonic stem cells lacking CpG binding protein.
    Carlone DL; Lee JH; Young SR; Dobrota E; Butler JS; Ruiz J; Skalnik DG
    Mol Cell Biol; 2005 Jun; 25(12):4881-91. PubMed ID: 15923607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation.
    Hendrich B; Bird A
    Curr Top Microbiol Immunol; 2000; 249():55-74. PubMed ID: 10802938
    [No Abstract]   [Full Text] [Related]  

  • 7. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
    Ballestar E; Esteller M
    Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-CpG binding proteins in the nervous system.
    Fan G; Hutnick L
    Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic prediction of DNA shape changes due to CpG methylation explains epigenetic effects on protein-DNA binding.
    Rao S; Chiu TP; Kribelbauer JF; Mann RS; Bussemaker HJ; Rohs R
    Epigenetics Chromatin; 2018 Feb; 11(1):6. PubMed ID: 29409522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology. MeCP2 repression goes nonglobal.
    Klose R; Bird A
    Science; 2003 Oct; 302(5646):793-5. PubMed ID: 14593157
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
    Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
    Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?
    Clouaire T; Stancheva I
    Cell Mol Life Sci; 2008 May; 65(10):1509-22. PubMed ID: 18322651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Activity and DNA Methylation in Humans.
    Światowy WJ; Drzewiecka H; Kliber M; Sąsiadek M; Karpiński P; Pławski A; Jagodziński PP
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal histone modifications on the inactive X chromosome in ICF and Rett syndrome cells: implications for methyl-CpG binding proteins.
    Gartler SM; Varadarajan KR; Luo P; Canfield TK; Traynor J; Francke U; Hansen RS
    BMC Biol; 2004 Sep; 2():21. PubMed ID: 15377381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific CpG hyper-methylation leads to Ankrd26 gene down-regulation in white adipose tissue of a mouse model of diet-induced obesity.
    Raciti GA; Spinelli R; Desiderio A; Longo M; Parrillo L; Nigro C; D'Esposito V; Mirra P; Fiory F; Pilone V; Forestieri P; Formisano P; Pastan I; Miele C; Beguinot F
    Sci Rep; 2017 Mar; 7():43526. PubMed ID: 28266632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation of the ABCG2 gene in renal carcinoma.
    To KK; Zhan Z; Bates SE
    Mol Cell Biol; 2006 Nov; 26(22):8572-85. PubMed ID: 16954373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
    Stirzaker C; Song JZ; Davidson B; Clark SJ
    Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of CpG and non-CpG methylation of Notch3 gene promoter determines its expression levels in breast cancer cells.
    Xiao W; Liu X; Niu X; Li C; Guo Y; Tan J; Xiong W; Fan L; Li Y
    Exp Cell Res; 2020 Jan; 386(2):111743. PubMed ID: 31770532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.